LifeSprout Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 12

LifeSprout General Information

Description

Developer of synthetic soft tissue substitutes designed to be used for aesthetic and reconstructive medicine in tissue reproduction. The company's tissue substitutes focus on the regrowth of human tissue by transferring tissue from one part of the body to another, enabling doctors to repair patients' soft tissue damage from trauma, natural aging, surgery, cancer, and metabolic disease

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 West Dickman Street
  • Suite 900
  • Baltimore, MD 21230
  • United States
+1 (410)
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Biotechnology
Vertical(s)
Corporate Office
  • 101 West Dickman Street
  • Suite 900
  • Baltimore, MD 21230
  • United States
+1 (410)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LifeSprout Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private Completed Pre-Clinical Trials
8. Later Stage VC (Series A) 31-Jan-2023 Completed Pre-Clinical Trials
7. Secondary Transaction - Private 13-Aug-2020 Completed Pre-Clinical Trials
6. Later Stage VC (Series A) 27-Apr-2020 Completed Pre-Clinical Trials
5. Debt - PPP 16-Apr-2020 Completed Pre-Clinical Trials
4. Seed Round 06-Mar-2019 Completed Pre-Clinical Trials
3. Accelerator/Incubator Completed Pre-Clinical Trials
2. Grant 01-Oct-2017 $1.42M $305K Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jul-2016 $305K $305K Completed Startup
To view LifeSprout’s complete valuation and funding history, request access »

LifeSprout Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view LifeSprout’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

LifeSprout Patents

LifeSprout Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4665784-A1 Collagen-hydrogel composite Pending 15-Feb-2023
WO-2024172909-A1 Collagen-hydrogel composite Inactive 15-Feb-2023
WO-2024172909-A9 Collagen-hydrogel composite Inactive 15-Feb-2023
EP-4665295-A1 Modified crosslinked polymers Pending 15-Feb-2023
US-20260234310-A1 Modified crosslinked polymers Pending 15-Feb-2023 C08F251/00
To view LifeSprout’s complete patent history, request access »

LifeSprout Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LifeSprout Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Medytox Venture Investment Corporate Venture Capital Minority
Nexus Management Corporation Minority
Redmile Group Venture Capital Minority
Kairos Ventures Venture Capital Minority
Medytox Corporation Minority
You’re viewing 5 of 12 investors. Get the full list »

LifeSprout FAQs

  • When was LifeSprout founded?

    LifeSprout was founded in 2015.

  • Where is LifeSprout headquartered?

    LifeSprout is headquartered in Baltimore, MD.

  • What is the size of LifeSprout?

    LifeSprout has 21 total employees.

  • What industry is LifeSprout in?

    LifeSprout’s primary industry is Drug Discovery.

  • Is LifeSprout a private or public company?

    LifeSprout is a Private company.

  • What is LifeSprout’s current revenue?

    The current revenue for LifeSprout is .

  • How much funding has LifeSprout raised over time?

    LifeSprout has raised $35.3M.

  • Who are LifeSprout’s investors?

    Medytox Venture Investment, Nexus Management, Redmile Group, Kairos Ventures, and Medytox are 5 of 12 investors who have invested in LifeSprout.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process